StonvexLoading…
StonvexStonvexStonvexCore line items from CLRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $18.70M | $25.20M |
Operating Income | $-4.40M | $-2.13M | $-6.77M | $-7.22M |
Net Income | $-26.08M | $-8.98M | $-560.00K | $20.56M |
EPS (Diluted) | $-14.77 | $-5.61 | $-0.02 | $0.83 |
Total Assets | $2.30M | $26.54M | $50.69M | $83.75M |
Total Liabilities | $3.01M | $5.21M | $6.01M | $9.62M |
Cash & Equivalents | $220.00K | $1.42M | $17.84M | $984.00K |
Free Cash Flow OCF − CapEx | Not available | $-6.31M | $54.25M | $-4.23M |
Shares Outstanding | 2.24M | 1.60M | 23.96M | 23.96M |